ストックスクリーナーアプリを入手
11.00
0.09%
-0.010
Research Alliance Corp Iii (RACC) 最新ニュース
Chutes & Ladders—Retirements at YNHHS, Deaconess, MUSC - Fierce Healthcare
Lupus Ventures Appoints Investment Committee, Scientific Advisory Network, and Unique Patient Council to Inform Fund Strategy - Morningstar
Eisai, UCL extend Alzheimer’s research alliance to 2030 - International Business Times
Price to book forward of Research Alliance Corporation III – NASDAQ:RACC - TradingView
Price to earnings forward of Research Alliance Corporation III – NASDAQ:RACC - TradingView
Price to sales forward of Research Alliance Corporation III – NASDAQ:RACC - TradingView
Research Alliance Corporation III (RACC) Earnings Yield (TTM) - Zacks Investment Research
Research Alliance Corporation III (RACC) Stock Price, News & Analysis - MarketBeat
RACC|Research Alliance III Ord Shs Class A|Price:10.550|Chg%:0.01 - TradingKey
Research Alliance Corporation III (RACC) Total Assets (Quarterly) - Zacks Investment Research
Research Alliance Corporation III (RACC) Eps Diluted - Zacks Investment Research
Research Alliance Corporation III (RACC) Revenue (TTM) - Zacks Investment Research
Research Alliance Corporation III (RACC) Total Expenses (TTM) - Zacks Investment Research
Research Alliance Corporation III (RACC) Revenue (Quarterly) - Zacks Investment Research
Research Alliance Corporation III (RACC) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
Research Alliance Corporation III (RACC) Debt Equity Ratio (Quarterly) - Zacks Investment Research
Research Alliance Corporation III (RACC) Cash From Operations (TTM) - Zacks Investment Research
Research Alliance Corporation III (RACC) Total Long Term Debt (Quarterly) - Zacks Investment Research
Research Alliance Corporation III (RACC) Price Book Value - Zacks Investment Research
RACC Technical Analysis & ETF Price Forecast - Intellectia AI
Latest RACC ETF News Today | Earnings, Events & Price Alerts - Intellectia AI
Marshall University names Gautam Pillay vice president for research, executive director of Marshall University Research Corporation - Marshall University
Number of employees of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Asset turnover of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Enterprise value of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Free float of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Debt to equity ratio of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
CapEx per share of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Free cash flow per share of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Diluted net income available to common stockholders of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Total liabilities of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
EBITDA of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Total debt of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Net debt of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Total liabilities & shareholders' equities of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Free cash flow of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Price to cash flow ratio of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Return on assets % of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Gross margin % of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
EBIT of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Taxes of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Net income of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Diluted earnings per share (diluted EPS) of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
After tax other income/expense of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Gross profit of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Operating income of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Dilution adjustment of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Non-controlling/minority interest of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Pretax income of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Diluted shares outstanding of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Basic earnings per share (basic EPS) of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Research Alliance Corp. IV Cash Flow – NASDAQ:RACD - TradingView
Non-operating income (total) of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Research Alliance Corp. IV Income Statement – NASDAQ:RACD - TradingView
Research Alliance Corp. IV Financial Statements – NASDAQ:RACD - TradingView
Total common shares outstanding of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Net current asset value per share of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Current ratio of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Net margin % of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Research Alliance Corp. IV Revenue Breakdown – NASDAQ:RACD - TradingView
Long term debt to total assets ratio of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Research Alliance Corp. IV Statistics – NASDAQ:RACD - TradingView
Enterprise value to EBITDA ratio of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
EBITDA margin % of Research Alliance Corp. IV – NASDAQ:RACD - TradingView
Research Alliance Corporation III (RACC) Stock Trends and Sentiment 2026 - MarketBeat
/C O R R E C T I O N — Melanoma Research Alliance/ - Morningstar
Texas Research Alliance Executive Director Appointed to Governor Abbott’s Quantum Initiative Advisory Committee - Weekly Voice
symbol__ Stock Quote Price and Forecast - CNN
Research Alliance Corporation III (RACC) Enterprise Value - Zacks Investment Research
Research Alliance Corporation III (RACC) Dividend (TTM) - Zacks Investment Research
Lilly offers up to $1B for Alzheimer’s drug; Bial cuts failed Parkinson’s drug - Endpoints News
Blank Check Co Research Alliance Corp Iv Files For $75 Million IPO Of 7.5 Million Class A SharesSEC Filing - TradingView
RACD IPO NewsRA Capital-backed SPAC Research Alliance Corp. IV files for a $75 million IPO, targeting healthcare - Renaissance Capital
0.13%
0.38%
大文字化:
|
ボリューム (24 時間):